LncRNA CYP1B1-AS1 as a clinical biomarker exacerbates sepsis inflammatory response via targeting miR- 18a- 5p
CYP1B1-AS1 serves as a biomarker for sepsis diagnosis and poor prognosis, potentially promoting inflammation and apoptosis by targeting miR- 18a- 5p.
Authors
- Qiushuang Zhang (ORCID: https://orcid.org/0000-0002-1084-9345)
- Jingpo Li
- Lixia Xu
- Qiuju Feng
- Li Li (ORCID: https://orcid.org/0000-0003-1802-9517)
- Lu Bai (ORCID: https://orcid.org/0000-0002-9415-4830)
Institutions
- Hebei General Hospital (CN)
Publication Details
- Journal
- BMC Immunology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1186/s12865-025-00712-9
- Citations
- 2
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 1.87